200,000+ products from a single source!
sales@angenechem.com
Home > Fluorides > 138786-67-1
138786-67-1 | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
CAS No: 138786-67-1 Catalog No: AG0019K2 MDL No:MFCD01658543
Product Description
Catalog Number:
AG0019K2
Chemical Name:
1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
CAS Number:
138786-67-1
Molecular Formula:
C16H15F2N3NaO4S
Molecular Weight:
406.3596
MDL Number:
MFCD01658543
IUPAC Name:
sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
InChI:
InChI=1S/C16H14F2N3O4S.Na/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;/h3-7,15H,8H2,1-2H3;/q-1;+1
InChI Key:
YNWDKZIIWCEDEE-UHFFFAOYSA-N
SMILES:
COc1c(OC)ccnc1CS(=O)c1nc2c([nH]1)cc(cc2)OC(F)F.[Na]
Properties
Complexity:
497
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
405.057g/mol
Formal Charge:
0
Heavy Atom Count:
27
Hydrogen Bond Acceptor Count:
10
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
405.352g/mol
Monoisotopic Mass:
405.057g/mol
Rotatable Bond Count:
7
Topological Polar Surface Area:
90.8A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Galloylquinic acid derivatives from Copaifera langsdorffii leaves display gastroprotective activity. | Chemico-biological interactions 20170105 |
| The influence of flavonoids on the binding of pantoprazole to bovine serum albumin by spectroscopic methods: with the viewpoint of food/drug interference. | Food chemistry 20121201 |
| Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. | International journal of pharmaceutics 20121115 |
| Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS. | Journal of pharmaceutical and biomedical analysis 20121101 |
| Prolonged coagulopathy related to coumarin rodenticide in a young patient: superwarfarin poisoning. | Cardiovascular journal of Africa 20121023 |
| Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. | Alimentary pharmacology & therapeutics 20121001 |
| Validation of a chiral liquid chromatography-tandem mass spectrometry method for the determination of pantoprazole in dog plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20121001 |
| CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers. | European journal of clinical pharmacology 20120901 |
| Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. | Drug metabolism and disposition: the biological fate of chemicals 20120901 |
| Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. | World journal of gastroenterology 20120828 |
| Allergic reaction to proton pump ınhibitor: pantoprazole induced Kounis syndrome. | International journal of cardiology 20120823 |
| Regulated endocrine-specific protein 18 (RESP18) is localized to and regulated in A-like cells and G-cells in rat stomach. | Regulatory peptides 20120820 |
| A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure. | Helicobacter 20120801 |
| Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. | Journal of cellular biochemistry 20120701 |
| Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients. | Nephrology (Carlton, Vic.) 20120701 |
| Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease. | Alimentary pharmacology & therapeutics 20120701 |
| [Clinical signs of Cushing's syndrome after long-term local application of steroid in the oral cavity]. | Ugeskrift for laeger 20120625 |
| The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. | Kidney international 20120601 |
| Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20120601 |
| Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. | Therapeutic drug monitoring 20120601 |
| Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. | Calcified tissue international 20120601 |
| Optimization and validation of a new CE method for the determination of pantoprazole enantiomers. | Electrophoresis 20120601 |
| Reflux symptom index and reflux finding score in otolaryngologic practice. | Journal of voice : official journal of the Voice Foundation 20120501 |
| Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study. | Nephrology (Carlton, Vic.) 20120501 |
| Stereoselective interaction of pantoprazole with ABCG2. I. Drug accumulation in rat milk. | Drug metabolism and disposition: the biological fate of chemicals 20120501 |
| Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis. | Drug metabolism and disposition: the biological fate of chemicals 20120501 |
| Dysphagia, oral telangiectasia, and Raynaud syndrome. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120401 |
| Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group. | Chirality 20120401 |
| Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. | Alimentary pharmacology & therapeutics 20120401 |
| Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. | Journal of gastroenterology and hepatology 20120301 |
| In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins. | Acta dermato-venereologica 20120301 |
| Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120301 |
| A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. | Helicobacter 20120201 |
| 33-year-old woman with epigastric pain and hematemesis. | Mayo Clinic proceedings 20120201 |
| Exfoliative erythrodermia induced by pantoprazole. | Allergologia et immunopathologia 20120101 |
| CYP2C19 genotypes determine the efficacy of on-demand therapy of pantoprazole for reflux esophagitis as Los-Angeles grades C and D. | Journal of gastroenterology and hepatology 20120101 |
| Prediction of clopidogrel low responders by a rapid CYP2C19 activity test. | Journal of atherosclerosis and thrombosis 20120101 |
| Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells. | Neoplasma 20120101 |
| Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study. | Medical science monitor : international medical journal of experimental and clinical research 20120101 |
| Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis. | BMC gastroenterology 20120101 |
| Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats. | Acta poloniae pharmaceutica 20120101 |
| Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention. | Pharmacological reports : PR 20120101 |
| Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Nine cases of allergy to omeprazole. | Journal of investigational allergology & clinical immunology 20120101 |
| [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. | Terapevticheskii arkhiv 20120101 |
| Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. | Pharmacological reports : PR 20120101 |
| [Prevention of stress-induced damage of the upper gastrointestinal mucosa in patients during early postoperative period]. | Anesteziologiia i reanimatologiia 20120101 |
| The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori. | Medical archives (Sarajevo, Bosnia and Herzegovina) 20120101 |
| Differential effects of Cu(II) and Fe(III) on the binding of omeprazole and pantoprazole to bovine serum albumin: toxic effect of metal ions on drugs. | Journal of pharmaceutical and biomedical analysis 20111215 |
| Antiprotozoal activity of proton-pump inhibitors. | Bioorganic & medicinal chemistry letters 20111215 |
| In vitro effect of pantoprazole on lower esophageal sphincter tone in rats. | World journal of gastroenterology 20111214 |
| [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201 |
| Effective administration method of intravenous proton pump inhibitor: a novel testing using a BRAVO catheterless pH monitoring system. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20111201 |
| Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20111101 |
| The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. | Drug metabolism and disposition: the biological fate of chemicals 20111101 |
| Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. | Alimentary pharmacology & therapeutics 20111101 |
| [Asymptomatic hypomagnesemic hypoparathyroidism induced by pantoprazol]. | Medicina clinica 20111022 |
| Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. | Biochimie 20111001 |
| Proton-pump inhibitors in sleep-related breathing disorders: clinical response and predictive factors. | European journal of gastroenterology & hepatology 20111001 |
| Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter. | The Journal of pharmacy and pharmacology 20111001 |
| Recurrent hypomagnesemia with proton-pump inhibitor rechallenge. | Annals of internal medicine 20110920 |
| Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. | World journal of gastroenterology 20110807 |
| Pantoprazole for the prevention of gastrointestinal bleeding in high-risk patients with acute coronary syndromes. | Journal of critical care 20110801 |
| Anaphylaxis to pantoprazole during general anesthesia. | Journal of anesthesia 20110801 |
| Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease. | Clinical pharmacokinetics 20110801 |
| Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study. | Helicobacter 20110801 |
| Second-line Helicobacter pylori eradication: a randomized comparison of 1-week or 2-week bismuth-containing quadruple therapy. | Helicobacter 20110801 |
| Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. | Helicobacter 20110801 |
| Toxicology and toxicokinetics of oral pantoprazole in neonatal and juvenile dogs. | Birth defects research. Part B, Developmental and reproductive toxicology 20110801 |
| [Efficacy of sequential therapy with pantoprazole in gastro esophageal reflux disease]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20110801 |
| Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. | World journal of gastroenterology 20110721 |
| Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease. | Scandinavian journal of gastroenterology 20110701 |
| A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease. | Journal of clinical pharmacology 20110601 |
| Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study. | Circulation. Cardiovascular interventions 20110601 |
| Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium. | The Journal of cardiovascular surgery 20110601 |
| Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions. | Journal of chromatography. A 20110520 |
| The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110501 |
| Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. | The Journal of laryngology and otology 20110501 |
| Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year. | Alimentary pharmacology & therapeutics 20110501 |
| Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. | Pediatrics 20110501 |
| Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. | European journal of gastroenterology & hepatology 20110501 |
| Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite. | The Annals of pharmacotherapy 20110401 |
| False elevation of chromogranin A due to proton pump inhibitors. | The Netherlands journal of medicine 20110401 |
| Population pharmacokinetic modeling of pantoprazole in pediatric patients from birth to 16 years. | Journal of clinical pharmacology 20110301 |
| [A case of Menetrier's disease showing mucus bridge observed during endoscopy]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110301 |
| Clopidogrel with or without omeprazole in coronary disease. | The New England journal of medicine 20110217 |
| Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease. | Digestive diseases and sciences 20110201 |
| Effect of Helicobacter pylori infection on symptoms of gastroenteritis due to enteropathogenic Escherichia coli in adults. | Digestive diseases and sciences 20110201 |
| Mechanisms of tumor growth retardation by modulation of pH regulation in the tumor-microenvironment of a murine T cell lymphoma. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110201 |
| Pantoprazole induces severe acute hepatitis. | Zeitschrift fur Gastroenterologie 20110201 |
| It is difficult to discontinue PPI treatment in patients with GERD. | The American journal of gastroenterology 20110201 |
| Pancreaticogastrostomy for high-risk gland after pancreaticoduodenectomy: an eligible choice? | World journal of surgery 20110101 |
| Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. | Clinical pharmacology and therapeutics 20110101 |
| Occupational airborne contact dermatitis caused by pantoprazole. | Contact dermatitis 20110101 |
| Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence study. | European journal of drug metabolism and pharmacokinetics 20110101 |
| Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction. | Autonomic & autacoid pharmacology 20110101 |
| [Preparation of pantoprazole sodium enteric-coated pellets-type tablets]. | Yao xue xue bao = Acta pharmaceutica Sinica 20110101 |
| Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. | BMC gastroenterology 20110101 |
| Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed? | Chemotherapy 20110101 |
| Comparison of the efficacy and safety of pantoprazole magnesium and pantoprazole sodium in the treatment of gastro-oesophageal reflux disease: a randomized, double-blind, controlled, multicentre trial. | Clinical drug investigation 20110101 |
| [Panum (pantoprazole) effectiveness in the treatment of patients with GERD]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers? | Digestion 20110101 |
| Pantoprazole provides myocardial protection similar to ischemic preconditioning: experimental study of isolated hearts of rats. | Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular 20110101 |
| [Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [Prevention of acute stress ulcer and gastrointestinal bleeding in patients with acute necrotizing pancreatitis]. | Anesteziologiia i reanimatologiia 20110101 |
| Opportunistic streptococcal gastritis in a patient with ulcerative colitis mimicking gastric involvement by inflammatory bowel disease. | Inflammatory bowel diseases 20101201 |
| Novel approaches to inhibition of gastric acid secretion. | Current gastroenterology reports 20101201 |
| Erlotinib and pantoprazole: a relevant interaction or not? | British journal of clinical pharmacology 20101201 |
| Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages. | Immunology letters 20101130 |
| Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. | Rheumatology (Oxford, England) 20101101 |
| Effects of pantoprazole in experimental acute pancreatitis. | Life sciences 20101023 |
| A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities. | Pharmacy world & science : PWS 20101001 |
| Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. | Southern medical journal 20101001 |
| Pantoprazole for symptoms of infant GERD: the emperor has no clothes! | Journal of pediatric gastroenterology and nutrition 20101001 |
| Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole. | The Netherlands journal of medicine 20101001 |
| [Microdialysis and HPLC method for determination of concentration of pantoprazole in rat striatum aftercombined administration with borneol]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101001 |
| Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis. | Clinical pediatrics 20100901 |
| Sequential therapy for Helicobacter pylori eradication. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100901 |
| Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on? | Journal of digestive diseases 20100801 |
| [Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20100801 |
| Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. | The American journal of gastroenterology 20100701 |
| Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole. | European journal of clinical pharmacology 20100701 |
| Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. | Journal of cardiovascular pharmacology 20100701 |
| Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20100701 |
| Education and imaging. Gastrointestinal: Scrub typhus induced acute gastric ulceration. | Journal of gastroenterology and hepatology 20100701 |
| Editorial: just how 'difficult' is it to withdraw PPI treatment? | The American journal of gastroenterology 20100701 |
| Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect. | Drug metabolism and disposition: the biological fate of chemicals 20100601 |
| Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). | European journal of clinical pharmacology 20100601 |
| Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. | Scandinavian journal of gastroenterology 20100601 |
| Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. | Journal of pediatric gastroenterology and nutrition 20100601 |
| Development and validation of a sensitive bioanalytical method for the quantitative estimation of pantoprazole in human plasma samples by LC-MS/MS: application to bioequivalence study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100601 |
| [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors]. | Medicina clinica 20100508 |
| [Efficacy and tolerability of pantoprazole in the treatment of gastroesophageal reflux disease]. | MMW Fortschritte der Medizin 20100506 |
| Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B. | The American journal of gastroenterology 20100501 |
| Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100501 |
| Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. | European journal of gastroenterology & hepatology 20100501 |
| Effect of corticosteroids during ongoing drug exposure in pantoprazole-induced interstitial nephritis. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100501 |
| Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. | Alimentary pharmacology & therapeutics 20100501 |
| Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors. | QJM : monthly journal of the Association of Physicians 20100501 |
| [13C]pantoprazole breath test as a predictor of the anti-platelet function of clopidogrel. | European journal of clinical pharmacology 20100501 |
| [Efficacy and tolerability of pantoprazole in the treatment of gastroesophageal reflux disease]. | MMW Fortschritte der Medizin 20100408 |
| The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. | Critical care medicine 20100401 |
| Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin. | Helicobacter 20100401 |
| Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. | Clinical therapeutics 20100401 |
| Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori. | World journal of gastroenterology 20100314 |
| The effect of mastic gum on Helicobacter pylori: a randomized pilot study. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301 |
| Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. | Southern medical journal 20100301 |
| The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials. | European journal of gastroenterology & hepatology 20100301 |
| A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. | British journal of clinical pharmacology 20100301 |
| Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction. | Clinical cardiology 20100301 |
| Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration. | Journal of pharmaceutical sciences 20100201 |
| Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201 |
| Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. | Annals of internal medicine 20100105 |
| Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding. | Annals of internal medicine 20100105 |
| Rapidly progressing glomerulonephritis secondary to henoch-schonlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation. | American journal of therapeutics 20100101 |
| A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism. | Alimentary pharmacology & therapeutics 20100101 |
| Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. | Gastroenterology 20100101 |
| Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis. | Journal of gastroenterology and hepatology 20100101 |
| Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial. | Digestion 20100101 |
| Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan? | Journal of gastroenterology and hepatology 20100101 |
| Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium. | Arzneimittel-Forschung 20100101 |
| Efficacy and pharmacokinetics of pantoprazole in alpacas. | Journal of veterinary internal medicine 20100101 |
| Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients. | Digestion 20100101 |
| Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101 |
| Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap. | Pediatric dermatology 20100101 |
| Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. | Clinical drug investigation 20100101 |
| [Acute psychosis induced by a Helicobacter pylori (H. pylori)-eradication treatment with amoxicillin, clarithromycin and pantoprazole]. | Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20100101 |
| Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers. | Arzneimittel-Forschung 20100101 |
| Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets. | Drug testing and analysis 20100101 |
| High-performance liquid chromatographic determination of pantoprazole and its main impurities in pharmaceuticals. | Journal of AOAC International 20100101 |
| Validation of a novel, fully automated high throughput high-performance liquid chromatographic/tandem mass Spectrometric method for quantification of pantoprazole in human plasma. | Journal of AOAC International 20100101 |
| [Pharmacokinetics of the proton pump inhibitors and psychological status in patients as factors that influence the efficiency of treatment of GERD with pantoprazole]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori. | World journal of gastroenterology 20091207 |
| Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. | The American journal of the medical sciences 20091201 |
| [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]. | Presse medicale (Paris, France : 1983) 20091201 |
| Ranitidine is unable to maintain gastric pH levels above 4 in septic patients. | Journal of critical care 20091201 |
| Pantoprazole-induced thrombocytopenia. | Indian journal of pediatrics 20091201 |
| Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women. | Prescrire international 20091201 |
| Bioequivalence among three methods of administering pantoprazole granules in healthy subjects. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101 |
| Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. | Southern medical journal 20091101 |
| (13)C breath tests in personalized medicine: fiction or reality? | Expert review of molecular diagnostics 20091101 |
| A rare cause of hyponatraemia? | British journal of hospital medicine (London, England : 2005) 20091101 |
| Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea. | Journal of gastroenterology and hepatology 20091001 |
| Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers. | Journal of clinical pharmacology 20091001 |
| Periodontal therapy improves gastric Helicobacter pylori eradication. | Journal of dental research 20091001 |
| Preparation and characterization of superporous hydrogels as pH-sensitive drug delivery system for Pantoprazole sodium. | Current drug delivery 20091001 |
| Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. | Journal of the American College of Cardiology 20090922 |
| Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. | The Journal of allergy and clinical immunology 20090901 |
| Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. | Chest 20090801 |
| [13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole. | Alimentary pharmacology & therapeutics 20090801 |
| Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. | American journal of physiology. Gastrointestinal and liver physiology 20090801 |
| Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. | Digestive diseases and sciences 20090701 |
| Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. | Biomedical chromatography : BMC 20090701 |
| Drug-drug interaction between clopidogrel and the proton pump inhibitors. | The Annals of pharmacotherapy 20090701 |
| Performance of acidified 14C-urea capsule breath test during pantoprazole and ranitidine treatment. | Journal of gastroenterology and hepatology 20090701 |
| Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090701 |
| Do the association of cytochrome P450 interacting drugs, influence clopidogrel efficacity? | American heart journal 20090701 |
| Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation. | Journal of gastroenterology and hepatology 20090701 |
| Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. | Journal of gastroenterology and hepatology 20090701 |
| Interaction between clopidogrel and proton pump inhibitors. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609 |
| Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study. | Alimentary pharmacology & therapeutics 20090601 |
| Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers. | Clinical research in cardiology : official journal of the German Cardiac Society 20090601 |
| Agglomerates containing pantoprazole microparticles: modulating the drug release. | AAPS PharmSciTech 20090601 |
| Proton pump inhibitors and clopidogrel: a difficult dilemma. | American heart journal 20090601 |
| Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090601 |
| The impact of normalization of esophageal acid profile by incremental protein pump inhibitors dosing in difficult asthma patients with proven gastro-esophageal acid reflux. | The Journal of asthma : official journal of the Association for the Care of Asthma 20090601 |
| Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study. | Digestive diseases and sciences 20090501 |
| Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study. | Alimentary pharmacology & therapeutics 20090501 |
| Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD. | Journal of clinical gastroenterology 20090401 |
| Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test. | The Journal of pharmacology and experimental therapeutics 20090401 |
| Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit? | Thrombosis and haemostasis 20090401 |
| Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. | Thrombosis and haemostasis 20090401 |
| Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20090401 |
| Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo. | Current drug delivery 20090401 |
| International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20090315 |
| Acute allergic interstitial nephritis after use of pantoprazole. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090303 |
| Effects of pantoprazole on ulcer healing delay associated with NSAID treatment. | Naunyn-Schmiedeberg's archives of pharmacology 20090301 |
| Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. | Alimentary pharmacology & therapeutics 20090301 |
| Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage. | Pharmacotherapy 20090301 |
| Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER). | Zeitschrift fur Gastroenterologie 20090301 |
| Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report. | Pharmacopsychiatry 20090301 |
| Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. | World journal of gastroenterology 20090227 |
| Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | World journal of gastroenterology 20090227 |
| The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. | Investigational new drugs 20090201 |
| Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin. | Journal of gastroenterology and hepatology 20090201 |
| Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. | Journal of clinical pharmacy and therapeutics 20090201 |
| Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients. | British journal of clinical pharmacology 20090201 |
| Blood concentration of pantoprazole sodium is significantly high in hepatogenic peptic ulcer patients, especially those with a poor CYP2C19 metabolism. | Journal of digestive diseases 20090201 |
| [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived]. | MMW Fortschritte der Medizin 20090129 |
| [Taking metabolic pathways into consideration. Approved drug against problematic interactions ]. | MMW Fortschritte der Medizin 20090129 |
| Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use. | Gastrointestinal endoscopy 20090101 |
| Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. | American heart journal 20090101 |
| Pharmacokinetic study of S-1. | International journal of clinical pharmacology and therapeutics 20090101 |
| A comparative study of proton-pump inhibitor tests for Chinese reflux patients in relation to the CYP2C19 genotypes. | Journal of clinical gastroenterology 20090101 |
| Comparison of hemostatic efficacy for argon plasma coagulation and distilled water injection in treating high-risk bleeding ulcers. | Journal of clinical gastroenterology 20090101 |
| Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion. | PloS one 20090101 |
| [Why some proton pump inhibitors are more equal than others]. | Nederlands tijdschrift voor geneeskunde 20090101 |
| Negative chronotropic effect of proton pump inhibitors on frog-heart preparation. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20090101 |
| Pantoprazole: a proton pump inhibitor. | Clinical drug investigation 20090101 |
| Severe gastro-oesophageal reflux disease. | Clinical drug investigation 20090101 |
| Gastro-oesophageal reflux disease in an obese patient. | Clinical drug investigation 20090101 |
| Chronic cough--about a clinical case.. | Clinical drug investigation 20090101 |
| Recurrent duodenal ulcer due to nonsteroidal anti-inflammatories following the suspension of antiulcer medication. | Clinical drug investigation 20090101 |
| Low-dose aspirin reduces gastro-protective properties of COX-2 selective inhibitors. | Clinical drug investigation 20090101 |
| Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome. | Cardiology journal 20090101 |
| [Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis]. | Likars'ka sprava 20090101 |
| [Eosinophilic gastritis after helicobacter pylori eradication]. | Zeitschrift fur Gastroenterologie 20081201 |
| Itopride and pantoprazole outcomes in diabetic gastroparesis trial (IPOD trial). | Journal of the Indian Medical Association 20081201 |
| Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial). | World journal of gastroenterology 20081114 |
| The eradication of Helicobacter pylori is affected by body mass index (BMI). | Obesity surgery 20081101 |
| Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents. | Journal of clinical pharmacology 20081101 |
| Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stressed related mucosal disease. | The Journal of trauma 20081101 |
| Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis. | The Journal of the Association of Physicians of India 20081101 |
| [Acute and subacute renal failure]. | Praxis 20081008 |
| [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts]. | MMW Fortschritte der Medizin 20081002 |
| [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. | Presse medicale (Paris, France : 1983) 20081001 |
| Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20081001 |
| IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study. | Allergy 20080901 |
| Skeptical that pantoprazole dose can prevent bleeding. | American journal of critical care : an official publication, American Association of Critical-Care Nurses 20080901 |
| Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy. | Surgical endoscopy 20080801 |
| Increasing sodium pantoprazole photostability by microencapsulation: effect of the polymer and the preparation technique. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080801 |
| Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. | Journal of gastroenterology and hepatology 20080801 |
| Randomized placebo-controlled trial of pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20080801 |
| [Intravenous proton-pump inhibitor for acute peptic ulcer bleeding--is profound acid suppression beneficial to reduce the risk of rebleeding?]. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20080801 |
| [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801 |
| Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. | Alimentary pharmacology & therapeutics 20080701 |
| Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia. | Current medical research and opinion 20080701 |
| Famotidine versus pantoprazole. | American journal of critical care : an official publication, American Association of Critical-Care Nurses 20080701 |
| Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat. | Pharmacological research 20080701 |
| A pilot study of efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis. | Digestive diseases and sciences 20080601 |
| Oral impact of gastro-oesophageal reflux disease: a case report. | Australian dental journal 20080601 |
| Development and in vitro evaluation of pantoprazole-loaded microspheres. | Drug delivery 20080601 |
| Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. | British journal of clinical pharmacology 20080501 |
| Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers. | Journal of separation science 20080501 |
| Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. | The Journal of trauma 20080501 |
| [Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501 |
| Intravenous pantoprazole utilization in a level 1 trauma center. | Surgical endoscopy 20080401 |
| Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains. | The Laryngoscope 20080401 |
| Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080401 |
| Pantoprazole: from drug metabolism to clinical relevance. | Expert opinion on drug metabolism & toxicology 20080401 |
| [The effect of proton pump inhibitor on healing of post-esophageal variceal ligation ulcers]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080401 |
| Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. | American journal of critical care : an official publication, American Association of Critical-Care Nurses 20080301 |
| Bleeding in the upper part of the gastrointestinal tract due to stress ulcers. | American journal of critical care : an official publication, American Association of Critical-Care Nurses 20080301 |
| Severe anemia associated with transient ischemic attacks involving vertebrobasilar circulation. | The American journal of emergency medicine 20080301 |
| Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. | Clinical therapeutics 20080301 |
| Long-term proton pump inhibitor use in children: a retrospective review of safety. | Digestive diseases and sciences 20080201 |
| EMANCIPATE study: drawing conclusions may be difficult in the absence of fundamental information. | European journal of gastroenterology & hepatology 20080201 |
| EMANCIPATE versus EXPO: different results can be explained by differing study designs. | European journal of gastroenterology & hepatology 20080201 |
| Determination of the enantiomeric impurity in S-(-)pantoprazole using high performance liquid chromatography with sulfobutylether-beta-cyclodextrin as chiral additive. | Journal of separation science 20080201 |
| Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects. | Clinical pharmacokinetics 20080101 |
| Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. | Acta dermato-venereologica 20080101 |
| Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer. | Cancer science 20080101 |
| Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection. | Journal of gastroenterology 20080101 |
| Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. | Clinical pharmacokinetics 20080101 |
| Stereoselective disposition of proton pump inhibitors. | Clinical drug investigation 20080101 |
| Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study. | Clinical drug investigation 20080101 |
| Comparative bioavailability study with two pantoprazole delayed-released tablet formulations administered with and without food in healthy subjects. | Arzneimittel-Forschung 20080101 |
| The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia. | Hepato-gastroenterology 20080101 |
| Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study. | Digestion 20080101 |
| A rapid high-performance liquid chromatographic method for the determination of pantoprazole in plasma using UV detection. Application in pharmacokinetic studies. | Arzneimittel-Forschung 20080101 |
| Bioequivalence study of two enteric-coated formulations of pantoprazole in healthy volunteers under fed conditions. | Arzneimittel-Forschung 20080101 |
| Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. | Clinical drug investigation 20080101 |
| Gastric atrophy and intestinal metaplasia in a patient on long-term proton pump inhibitor therapy. | Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20080101 |
| [Efficacy of pantoprazole in the therapy of esophageal reflux disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Using sunpraz in GERD]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Use of sunpraz in treating duodenal ulcer: performance test report]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Stability of pantoprazole in parenteral nutrition units]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101 |
| [Preparation sanpraz (pantoprazole): experience of application in treatment of gastroesophageal reflux disease and other acid related diseases]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Antisecretory potential of pantoprasole (sanpraz)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs]. | MMW Fortschritte der Medizin 20071206 |
| [Focus on multi-morbidity patients. Considering the greatest measure of therapy safety]. | MMW Fortschritte der Medizin 20071206 |
| A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. | Helicobacter 20071201 |
| Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. | Helicobacter 20071201 |
| A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection. | Journal of Korean medical science 20071201 |
| Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. | Expert review of gastroenterology & hepatology 20071201 |
| [Drug treatment and surgical indications in gastroesophageal reflux]. | Revista de gastroenterologia de Mexico 20071101 |
| Structural identification and characterization of potential impurities of pantoprazole sodium. | Journal of pharmaceutical and biomedical analysis 20071018 |
| Emergency department drug orders: does drug storage location make a difference? | Annals of emergency medicine 20071001 |
| Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population. | Helicobacter 20071001 |
| Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. | World journal of gastroenterology 20070907 |
| Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. | Chirality 20070901 |
| Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. | Digestive diseases and sciences 20070901 |
| Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients. | Journal of gastroenterology and hepatology 20070901 |
| Inlet patch presenting with food impaction caused by peptic stricture. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070901 |
| The prevalence of pantoprozole associated thrombocytopenia in a community hospital. | Expert opinion on pharmacotherapy 20070901 |
| Comparative tolerability of 2- and 15-minute intravenous infusions of pantoprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070901 |
| The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study. | European journal of clinical pharmacology 20070801 |
| Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. | ANZ journal of surgery 20070801 |
| Recent advances in chirally pure proton pump inhibitors. | Journal of the Indian Medical Association 20070801 |
| Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis. | Alimentary pharmacology & therapeutics 20070715 |
| Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. | Circulation 20070703 |
| Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. | Age and ageing 20070701 |
| A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving 'complete remission' in gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20070615 |
| High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding. | The American journal of gastroenterology 20070601 |
| Characterizing early prescribers of newly marketed drugs in Canada: a population-based study. | European journal of clinical pharmacology 20070601 |
| A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? | Helicobacter 20070601 |
| Sphincter of Oddi function in the Australian brush-tailed possum is inhibited by intragastric ethanol. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20070501 |
| Development of HPMC and Eudragit S100 blended microparticles containing sodium pantoprazole. | Die Pharmazie 20070501 |
| Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. | Journal of toxicology and environmental health. Part A 20070415 |
| Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole. | Journal of pharmaceutical and biomedical analysis 20070411 |
| A novel quantification method of pantaprazole sodium monohydrate in sesquihydrate by thermogravimetric analyzer. | Journal of pharmaceutical and biomedical analysis 20070411 |
| [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. | Orvosi hetilap 20070325 |
| Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study. | European journal of gastroenterology & hepatology 20070301 |
| [Reflux-associated nutcracker oesophagus in a 49-year-old patient with non-cardiac chest pain (NCCP)]. | Zeitschrift fur Gastroenterologie 20070301 |
| Bleeding Meckel diverticulum responds to intravenous pantoprazole. | Southern medical journal 20070301 |
| The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20070301 |
| Esophageal thermal injury by hot adlay tea. | The Korean journal of internal medicine 20070301 |
| What is the best first choice treatment option for Helicobacter pylori? | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20070301 |
| Long-term management of GERD in the elderly with pantoprazole. | Clinical interventions in aging 20070301 |
| Pharmacodynamic effects of single doses of rabeprazole 20 mg and pantoprazole 40 mg in patients with GERD and nocturnal heartburn. | Alimentary pharmacology & therapeutics 20070215 |
| Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding. | Alimentary pharmacology & therapeutics 20070201 |
| Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults. | European journal of gastroenterology & hepatology 20070201 |
| Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. | Alimentary pharmacology & therapeutics 20070115 |
| Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. | Digestive diseases and sciences 20070101 |
| Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments. | Journal of gastroenterology and hepatology 20070101 |
| Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease. | Clinical drug investigation 20070101 |
| Simultaneous estimation of pantoprazole and domperidone in pure powder and a pharmaceutical formulation by high-perfomance liquid chromatography and high-performance thin-layer chromatography methods. | Journal of AOAC International 20070101 |
| Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. | Digestion 20070101 |
| Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. | Digestion 20070101 |
| International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. | Digestion 20070101 |
| Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. | Digestion 20070101 |
| Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. | Digestion 20070101 |
| Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20070101 |
| Bioequivalence of two enteric coated formulations of pantoprazole in healthy volunteers under fasting and fed conditions. | Arzneimittel-Forschung 20070101 |
| Chronic oesophagitis dissecans: a case report. | Acta gastro-enterologica Belgica 20070101 |
| Evaluation of pantoprazol treatment response of patients with asthma and gastroesophageal reflux: a randomized prospective double-blind placebo-controlled study. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20070101 |
| Effect of pantoprazole in older patients with erosive esophagitis. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20070101 |
| The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire. | Clinical drug investigation 20070101 |
| [A survey of gastroprotective drugs: prescription-indication in hospitalized patients]. | Gaceta sanitaria 20070101 |
| Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(epsilon-caprolactone) blend. | Pharmaceutical development and technology 20070101 |
| Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects. A prospective, open, randomised, two-way cross-over comparative study. | Arzneimittel-Forschung 20070101 |
| [Use of pantoprazol for treatment of gastroesophageal reflux disease and NSAID-induced gastropathy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| [Safety of proton pump inhibitors]. | Medicina clinica 20061125 |
| [Reliable Helicobacter eradication. Combination package facilitates therapy]. | MMW Fortschritte der Medizin 20061109 |
| Endoscopic management of a new entity-plastobezoar: a case report and review of literature. | World journal of gastroenterology 20061107 |
| Metabolic alkalosis in a hemodialysis patient--successful treatment with a proton pump inhibitor. | Clinical nephrology 20061101 |
| Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation. | International journal of pharmaceutics 20061031 |
| Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. | Alimentary pharmacology & therapeutics 20061015 |
| An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile. | International journal of pharmaceutics 20061012 |
| Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease. | World journal of gastroenterology 20061007 |
| Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients. | European journal of clinical pharmacology 20061001 |
| Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility. | Journal of gastroenterology and hepatology 20061001 |
| Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). | Clinical pediatrics 20061001 |
| Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. | Nephrology (Carlton, Vic.) 20061001 |
| [Dosaging of proton pumps inhibitors]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060921 |
| Thyroxine in goiter, H. pylori infection, and gastritis. | The New England journal of medicine 20060914 |
| Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. | Alimentary pharmacology & therapeutics 20060901 |
| Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. | Digestive diseases and sciences 20060901 |
| Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. | The Journal of asthma : official journal of the Association for the Care of Asthma 20060901 |
| Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. | The American journal of gastroenterology 20060901 |
| Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. | The American journal of gastroenterology 20060901 |
| Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060901 |
| Esomeprazole versus pantoprazole for healing erosive oesophagitis. | Collegium antropologicum 20060901 |
| Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial. | Clinical therapeutics 20060901 |
| Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistant strains. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060901 |
| Effects of chronic therapy with non-steroidal antiinflammatory drugs on gastric permeability of sucrose: a study on 71 patients with rheumatoid arthritis. | World journal of gastroenterology 20060821 |
| Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. | The American journal of gastroenterology 20060801 |
| Kinetic spectrophotometric analysis of pantoprazole in commercial dosage forms. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20060701 |
| Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography. | Die Pharmazie 20060701 |
| Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux. | Ear, nose, & throat journal 20060701 |
| The complete remission concept. | Drugs of today (Barcelona, Spain : 1998) 20060701 |
| Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060601 |
| Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. | Chemical & pharmaceutical bulletin 20060601 |
| Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? | European journal of clinical pharmacology 20060601 |
| Eradication of Helicobacter pylori and dosages of esomeprazole. | The American journal of gastroenterology 20060601 |
| Bismuth-based therapies for the first step eradication of Helicobacter pylori. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060601 |
| Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20060515 |
| Proton pump inhibitors and acute interstitial nephritis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060501 |
| [Financial restrictions in health care systems could affect treatment quality of GERD-patients]. | Zeitschrift fur Gastroenterologie 20060501 |
| Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. | Clinical therapeutics 20060501 |
| Hydroxyl radical scavenging reactivity of proton pump inhibitors. | Biochemical pharmacology 20060428 |
| Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20060415 |
| Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study. | British journal of sports medicine 20060401 |
| Pantoprazole-induced thrombocytopenia. | The Annals of pharmacotherapy 20060401 |
| Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. | Alimentary pharmacology & therapeutics 20060401 |
| A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. | Clinical pharmacology and therapeutics 20060401 |
| Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. | Journal of pediatric gastroenterology and nutrition 20060401 |
| Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. | Journal of gastroenterology and hepatology 20060401 |
| Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis. | The Journal of rheumatology 20060301 |
| Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20060215 |
| Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. | Alimentary pharmacology & therapeutics 20060201 |
| Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis. | Digestive diseases and sciences 20060101 |
| Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. | Digestive diseases and sciences 20060101 |
| Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. | Gerontology 20060101 |
| Intravenous proton pump inhibitors. | Reviews in gastroenterological disorders 20060101 |
| Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. | Journal of investigational allergology & clinical immunology 20060101 |
| Effect of proton pump inhibitors on hepatic regeneration. | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101 |
| [Direct enantioseparation of pantoprazole sodium by high performance liquid chromatography on teicoplanin-bonded chiral stationary phase]. | Se pu = Chinese journal of chromatography 20060101 |
| Quality of life in GERD patients: medical treatment versus antireflux surgery. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060101 |
| Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20060101 |
| Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. | Digestion 20060101 |
| Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. | World journal of gastroenterology 20051228 |
| Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051201 |
| Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20051201 |
| Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051115 |
| Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. | Alimentary pharmacology & therapeutics 20051101 |
| Balanced perspective essential in erosive oesophagitis treatment. | Alimentary pharmacology & therapeutics 20051101 |
| Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings. | Archives of pathology & laboratory medicine 20051101 |
| A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. | The American journal of gastroenterology 20051101 |
| Helicobacter pylori: factors affecting eradication and recurrence. | The American journal of gastroenterology 20051101 |
| Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051101 |
| [Gastroesophageal reflux and obstructive sleep apnea syndrome]. | Acta otorrinolaringologica espanola 20051101 |
| [Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. | International journal of clinical practice 20051001 |
| Pharmacokinetic differences between pantoprazole enantiomers in rats. | Pharmaceutical research 20051001 |
| Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. | Current medical research and opinion 20051001 |
| Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy. | Scandinavian journal of gastroenterology 20051001 |
| Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. | European journal of gastroenterology & hepatology 20050901 |
| High-performance liquid chromatography method for the quantification of pantoprazole in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805 |
| Proton-pump-inhibitor-induced hepatitis. | Southern medical journal 20050801 |
| Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs. | The Journal of pharmacy and pharmacology 20050701 |
| Apparent anaphylaxis associated with pantoprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050701 |
| Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. | European journal of clinical pharmacology 20050701 |
| The healing course of thermal esophageal injury: a case report. | Gastrointestinal endoscopy 20050701 |
| Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals. | Equine veterinary journal 20050701 |
| Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. | Naunyn-Schmiedeberg's archives of pharmacology 20050701 |
| Understanding GERD symptoms in the clinical setting. | Drugs of today (Barcelona, Spain : 1998) 20050701 |
| Extraesophageal manifestations of GERD: diagnosis and therapy. | Drugs of today (Barcelona, Spain : 1998) 20050701 |
| Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20050615 |
| Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. | Journal of clinical pharmacology 20050501 |
| Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana. | Xenobiotica; the fate of foreign compounds in biological systems 20050501 |
| Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial. | Scandinavian journal of gastroenterology 20050501 |
| Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. | World journal of gastroenterology 20050421 |
| Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study. | Alimentary pharmacology & therapeutics 20050415 |
| The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. | Cancer research 20050401 |
| A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. | Alimentary pharmacology & therapeutics 20050315 |
| Physical characterization of pantoprazole sodium hydrates. | International journal of pharmaceutics 20050303 |
| Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. | Hepatology (Baltimore, Md.) 20050301 |
| Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene. | Die Pharmazie 20050301 |
| Metabolism of pantoprazole involving conjugation with glutathione in rats. | The Journal of pharmacy and pharmacology 20050301 |
| Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. | Digestive diseases and sciences 20050301 |
| Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. | American journal of veterinary research 20050301 |
| Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. | Irish medical journal 20050301 |
| A randomized controlled trial of equivalence between pantoprazole and esomeprazole that does not have the power to conclude. | Journal of clinical gastroenterology 20050201 |
| The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. | Alimentary pharmacology & therapeutics 20050201 |
| Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. | Gastrointestinal endoscopy 20050201 |
| Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. | European journal of gastroenterology & hepatology 20050101 |
| Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. | The American journal of managed care 20050101 |
| Probiotics: wanted dead or alive. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101 |
| Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101 |
| Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101 |
| Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. | Expert opinion on pharmacotherapy 20050101 |
| Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine. | Methods and findings in experimental and clinical pharmacology 20050101 |
| Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. | Digestion 20050101 |
| [Basic principles of successful GERD (gastroesophageal reflux disease) therapy]. | Krankenpflege Journal 20050101 |
| Pancreatitis due to codeine. | Allergologia et immunopathologia 20050101 |
| Simultaneous determination of pantoprazole and its two metabolites in dog plasma by HPLC. | Journal of chromatographic science 20050101 |
| On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. | Digestion 20050101 |
| A flow-injection biamperometric method for determination of pantoprazole in pharmaceutical tablets. | Journal of AOAC International 20050101 |
| [Eradication of Helicobacter pylori]. | Krankenpflege Journal 20050101 |
| Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats. | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20050101 |
| Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure. | Annals of Saudi medicine 20050101 |
| What is potent acid inhibition, and how can it be achieved? | Drugs 20050101 |
| Intravenous proton pump inhibitor therapy: a rationale for use. | Reviews in gastroenterological disorders 20050101 |
| Gastroesophageal reflux disease and extraesophageal disease. | Reviews in gastroenterological disorders 20050101 |
| [Reflux therapy in the elderly]. | Krankenpflege Journal 20050101 |
| Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. | World journal of gastroenterology 20041215 |
| Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041215 |
| Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. | Biochemical pharmacology 20041201 |
| Less acid + less bleeding = better outcomes and more money! | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20041201 |
| Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201 |
| Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. | Journal of the National Cancer Institute 20041117 |
| Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study. | Alimentary pharmacology & therapeutics 20041115 |
| Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis. | Alimentary pharmacology & therapeutics 20041115 |
| [Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy]. | MMW Fortschritte der Medizin 20041104 |
| [Attention! Cough, asthma and Co. are often caused by reflux]. | MMW Fortschritte der Medizin 20041104 |
| A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041101 |
| [Choice of proton pump inhibitors--does it play any role?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021 |
| [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia]. | Orvosi hetilap 20041017 |
| Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. | Journal of clinical psychopharmacology 20041001 |
| Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. | European journal of clinical pharmacology 20041001 |
| Recurrent anaphylaxis linked to pantoprazole. | The Journal of allergy and clinical immunology 20041001 |
| Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041001 |
| Excretion of pantoprazole in human breast. | The Journal of reproductive medicine 20041001 |
| Prevention of erosive oesophagitis relapse with pantoprazole. | Alimentary pharmacology & therapeutics 20040901 |
| Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20040901 |
| Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing. | The Laryngoscope 20040901 |
| Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. | The Laryngoscope 20040901 |
| Results of triple eradication therapy in Japanese children: a retrospective multicenter study. | Journal of gastroenterology 20040901 |
| Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. | Cancer research 20040815 |
| Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. | International immunopharmacology 20040801 |
| Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Drug metabolism and disposition: the biological fate of chemicals 20040801 |
| Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. | Saudi medical journal 20040801 |
| The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing. | Current medical research and opinion 20040801 |
| Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. | Journal of separation science 20040801 |
| Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage. | Connecticut medicine 20040801 |
| Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. | Alimentary pharmacology & therapeutics 20040701 |
| Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? | The American journal of gastroenterology 20040701 |
| Retrospective evaluation of the effect of omeprazole on clozapine metabolism. | Pharmacy world & science : PWS 20040601 |
| Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. | Pharmacological research 20040501 |
| [Studies on chiral inversion of dextropantoprazole in human]. | Yao xue xue bao = Acta pharmaceutica Sinica 20040501 |
| [Direct enantiomeric separation of pantoprazole sodium by high performance liquid chromatography]. | Se pu = Chinese journal of chromatography 20040501 |
| pH probe positioning for 24-hour pH-metry by manometry or pH step-up. | European journal of gastroenterology & hepatology 20040401 |
| An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease. | Endoscopy 20040401 |
| 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms. | Journal of clinical gastroenterology 20040401 |
| Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. | Journal of the Chinese Medical Association : JCMA 20040401 |
| [Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?]. | MMW Fortschritte der Medizin 20040311 |
| [Graded therapy in reflux disease. 'In severe cases 40 mg., in milder 20 mg.']. | MMW Fortschritte der Medizin 20040311 |
| [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence]. | Revista clinica espanola 20040301 |
| [Electrochemical behaviour of pantoprazole]. | Die Pharmazie 20040301 |
| GERD 2003: issues from the past and a consensus for the future. | Drugs of today (Barcelona, Spain : 1998) 20040301 |
| The basis of differentiation of PPIs. | Drugs of today (Barcelona, Spain : 1998) 20040301 |
| Understanding NSAID-PPI-COX-2 interrelationships. | Drugs of today (Barcelona, Spain : 1998) 20040301 |
| Quality of life after peptic perforation. | The Journal of the Association of Physicians of India 20040301 |
| The acidity index: a simple approach to the measurement of gastric acidity. | Alimentary pharmacology & therapeutics 20040215 |
| Acute interstitial nephritis due to pantoprazole. | The Annals of pharmacotherapy 20040101 |
| Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental model. | Surgery today 20040101 |
| [Cross reactivity among proton pump inhibitors: does it exits?]. | Allergologia et immunopathologia 20040101 |
| Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. | European journal of gastroenterology & hepatology 20040101 |
| Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard. | Arzneimittel-Forschung 20040101 |
| Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease. | Digestion 20040101 |
| Pantoprazole-induced acute interstitial nephritis. | Journal of nephrology 20040101 |
| [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer]. | Arquivos de gastroenterologia 20040101 |
| Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20040101 |
| Effectiveness of proton pump inhibitors: beyond cost. | Reviews in gastroenterological disorders 20040101 |
| [The proton pump especially steady in grip. Fast help for nightly reflux complaints]. | MMW Fortschritte der Medizin 20031218 |
| Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding. | Current gastroenterology reports 20031201 |
| Study of Mimusops elengi bark in experimental gastric ulcers. | Journal of ethnopharmacology 20031201 |
| Differential pulse anodic voltammetric determination of pantoprazole in pharmaceutical dosage forms and human plasma using glassy carbon electrode. | Analytical biochemistry 20031201 |
| Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. | Helicobacter 20031201 |
| Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. | The American journal of gastroenterology 20031201 |
| Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. | The American journal of gastroenterology 20031201 |
| Dosage of intravenous pantoprazole. | The American journal of gastroenterology 20031201 |
| [Efficacy of controloc in the treatment of acid-dependent diseases]. | Likars'ka sprava 20031201 |
| In treatment of active duodenal ulcer and Helicobacter pylori eradication. | Hepato-gastroenterology 20031201 |
| Square-wave adsorptive cathodic stripping voltammetry of pantoprazole. | Journal of pharmaceutical and biomedical analysis 20031124 |
| Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. | World journal of gastroenterology 20031115 |
| The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. | Anesthesia and analgesia 20031101 |
| ['Mirror, mirror on the wall which is the best proton pump inhibitor of all?']. | Zeitschrift fur Gastroenterologie 20031101 |
| [Treatment of reflux esophagitis by Xuanfu Daizhe Decoction combined with pantoprazole or omeprazole: a comparative study]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20031101 |
| [Mastopathy after estradiol and pantoprazol treatment]. | Atencion primaria 20031031 |
| Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. | Alimentary pharmacology & therapeutics 20031015 |
| Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. | Journal of pharmaceutical and biomedical analysis 20031015 |
| Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. | Alimentary pharmacology & therapeutics 20031001 |
| Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. | The American journal of managed care 20031001 |
| Treating patients with acute gastrointestinal bleeding or rebleeding. | Pharmacotherapy 20031001 |
| Asthma-like syndrome in a teenager. | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20031001 |
| Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms. | Alimentary pharmacology & therapeutics 20030915 |
| [Treatment of reflux disease. An international consensus conference put things in its place]. | Revue medicale de la Suisse romande 20030901 |
| First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. | Journal of pharmaceutical and biomedical analysis 20030808 |
| Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. | Journal of clinical gastroenterology 20030801 |
| [References for reflux therapy. Preventing nocturnal acid recurrence]. | MMW Fortschritte der Medizin 20030724 |
| [Pantoprazole-induced hepatitis]. | Deutsche medizinische Wochenschrift (1946) 20030704 |
| Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. | Surgical oncology 20030701 |
| Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease. | European journal of gastroenterology & hepatology 20030701 |
| Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode. | Farmaco (Societa chimica italiana : 1989) 20030701 |
| Adverse reactions to pantoprazole. | Scandinavian journal of gastroenterology 20030701 |
| Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701 |
| [All proton pump inhibitors are equally efficacious in standard dosages]. | Lakartidningen 20030619 |
| Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. | Alimentary pharmacology & therapeutics 20030615 |
| Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. | Alimentary pharmacology & therapeutics 20030601 |
| Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection. | The Netherlands journal of medicine 20030601 |
| Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. | Alimentary pharmacology & therapeutics 20030501 |
| Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030501 |
| Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. | Scandinavian journal of gastroenterology 20030501 |
| Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. | European journal of pharmacology 20030411 |
| [When sour does not make merry at all . Fast relief for patients with reflux]. | MMW Fortschritte der Medizin 20030410 |
| Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. | Helicobacter 20030401 |
| A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. | Alimentary pharmacology & therapeutics 20030401 |
| [Pantoprazole-induced hepatitis]. | Deutsche medizinische Wochenschrift (1946) 20030321 |
| Update on prescribing information for pantoprazole. | American family physician 20030315 |
| Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. | The Annals of pharmacotherapy 20030301 |
| Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study. | Medical electron microscopy : official journal of the Clinical Electron Microscopy Society of Japan 20030301 |
| Synthesis or rupture: duration of acid inhibition by proton pump inhibitors. | Drugs of today (Barcelona, Spain : 1998) 20030301 |
| Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030301 |
| [Exaggerated interaction claims. With esomeprazole the data corroborate safety]. | MMW Fortschritte der Medizin 20030206 |
| Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children. | Journal of pediatric gastroenterology and nutrition 20030201 |
| Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. | The American journal of gastroenterology 20030201 |
| Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test. | Digestive diseases and sciences 20030201 |
| A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands. | Clinical therapeutics 20030201 |
| Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. | Drugs 20030101 |
| Severe esophagitis healed in less than a week with intravenous pantoprazole. | Journal of clinical gastroenterology 20030101 |
| Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. | Alimentary pharmacology & therapeutics 20030101 |
| Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test. | The American journal of gastroenterology 20030101 |
| The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England. | Drug safety 20030101 |
| Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. | Alimentary pharmacology & therapeutics 20030101 |
| Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study. | Digestion 20030101 |
| ['Visual assessment' does not replace quality control with instrumental methods]. | Wiener medizinische Wochenschrift (1946) 20030101 |
| The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. | Arquivos de gastroenterologia 20030101 |
| [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. | Klinicheskaia meditsina 20030101 |
| An overview of proton pump inhibitors. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101 |
| Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. | Journal of pediatric gastroenterology and nutrition 20030101 |
| Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. | Digestion 20030101 |
| [Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers]. | Acta gastroenterologica Latinoamericana 20030101 |
| [Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101 |
| The pharmacology and clinical relevance of proton pump inhibitors. | Current gastroenterology reports 20021201 |
| Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study. | Alimentary pharmacology & therapeutics 20021201 |
| Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. | Journal of pharmaceutical and biomedical analysis 20021107 |
| Pantoprazole-induced recurrent anaphylactic shock. | The American journal of gastroenterology 20021101 |
| [Patient with increased stomach cancer risk. Helicobacter can cause damage here]. | MMW Fortschritte der Medizin 20021024 |
| Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. | The Medical journal of Australia 20021021 |
| [In small steps to far ahead. Diminished risk of interactions as definite advantage]. | MMW Fortschritte der Medizin 20021010 |
| Factors associated with treatment failure of Helicobacter pylori infection in a developing country. | Journal of clinical gastroenterology 20021001 |
| [Proton pump inhibitor in reflux disease. Administer for maximum effect from the beginning]. | MMW Fortschritte der Medizin 20020926 |
| [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. | Zhonghua yi xue za zhi 20020925 |
| Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. | Journal of voice : official journal of the Voice Foundation 20020901 |
| Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20020801 |
| Proton pump inhibitors: an update. | American family physician 20020715 |
| Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020701 |
| Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. | BMJ (Clinical research ed.) 20020622 |
| Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. | Alimentary pharmacology & therapeutics 20020601 |
| A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. | European journal of gastroenterology & hepatology 20020601 |
| Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. | Critical care medicine 20020601 |
| Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. | Critical care medicine 20020601 |
| Intravenous proton pump inhibitors in the critical care setting. | Critical care medicine 20020601 |
| Pantoprazole-induced recurrent anaphylactic shock. | The American journal of gastroenterology 20020601 |
| Stability of pantoprazole in an extemporaneously compounded oral liquid. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020515 |
| Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study. | Journal of clinical pharmacology 20020501 |
| Pantoprazole IV (Protonix IV). | The Medical letter on drugs and therapeutics 20020429 |
| Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. | Alimentary pharmacology & therapeutics 20020401 |
| Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. | European journal of gastroenterology & hepatology 20020401 |
| Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. | Gastroenterologie clinique et biologique 20020401 |
| Review article: rabeprazole-based therapy in Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020301 |
| Acid suppression in healthy subjects following lansoprazole or pantoprazole. | Alimentary pharmacology & therapeutics 20020301 |
| Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test. | Alimentary pharmacology & therapeutics 20020301 |
| Protonix. First i.v. proton pump inhibitor approved. | Nursing 20020201 |
| Nonallergic anaphylaxis to pantoprazole. | Allergy 20020201 |
| [Proton pump inhibitors: Pantoprazole]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| Conformational analysis: a new approach by means of chemometrics. | Journal of computational chemistry 20020130 |
| Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020105 |
| The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome. | Journal of clinical gastroenterology 20020101 |
| [Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101 |
| Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20020101 |
| [Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer]. | Gastroenterologia y hepatologia 20020101 |
| Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. | American journal of therapeutics 20020101 |
| Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection. | Hepato-gastroenterology 20020101 |
| [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| Mixed infection due to leptospira and dengue. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101 |
| The clinical importance of proton pump inhibitor pharmacokinetics. | Digestion 20020101 |
| [Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)]. | Wiener medizinische Wochenschrift (1946) 20020101 |
| Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis. | Arquivos de gastroenterologia 20020101 |
| Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). | Wiener klinische Wochenschrift 20011217 |
| Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. | Alimentary pharmacology & therapeutics 20011201 |
| Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. | Naunyn-Schmiedeberg's archives of pharmacology 20011201 |
| Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20011201 |
| Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. | The American journal of gastroenterology 20011201 |
| Proton pump inhibitors and gastric acid secretion. | The American journal of gastroenterology 20011201 |
| A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH. | Alimentary pharmacology & therapeutics 20011101 |
| Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. | Annals of surgery 20011101 |
| Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. | European journal of gastroenterology & hepatology 20011101 |
| Cluster headache without autonomic symptoms? | Cephalalgia : an international journal of headache 20011101 |
| Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis. | Alimentary pharmacology & therapeutics 20011001 |
| Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. | The American journal of gastroenterology 20011001 |
| Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. | Acta oto-laryngologica 20011001 |
| [Comparative study of proton pump inhibitors]. | Orvosi hetilap 20010909 |
| Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. | Alimentary pharmacology & therapeutics 20010901 |
| Resolution of Menetrier's disease after Helicobacter pylori eradication therapy. | The New Zealand medical journal 20010824 |
| No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. | European journal of gastroenterology & hepatology 20010801 |
| Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction. | Clinical therapeutics 20010801 |
| Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? | Alimentary pharmacology & therapeutics 20010701 |
| Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. | Alimentary pharmacology & therapeutics 20010701 |
| Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. | Alimentary pharmacology & therapeutics 20010701 |
| Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. | The American journal of gastroenterology 20010701 |
| Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine. | European journal of gastroenterology & hepatology 20010701 |
| Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. | Clinical and experimental dermatology 20010701 |
| Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. | Clinical therapeutics 20010701 |
| Proton pump inhibitors: a study of GPs' prescribing. | Family practice 20010601 |
| Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20010601 |
| Pantoprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010601 |
| Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. | The American journal of gastroenterology 20010601 |
| Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases. | Digestive diseases and sciences 20010501 |
| Proton pump inhibitors and their drug interactions: an evidence-based approach. | European journal of gastroenterology & hepatology 20010501 |
| Shortcomings of the first-generation proton pump inhibitors. | European journal of gastroenterology & hepatology 20010501 |
| [H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. | La Revue du praticien 20010415 |
| Pantoprazole and cyclosporine or tacrolimus. | Alimentary pharmacology & therapeutics 20010401 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. | Life sciences 20010309 |
| Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin. | Clinical pharmacology and therapeutics 20010301 |
| Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats. | Cell and tissue research 20010301 |
| Pantoprazole versus lansoprazole in French patients with reflux esophagitis. | Gastroenterologie clinique et biologique 20010301 |
| Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study. | Croatian medical journal 20010201 |
| Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats. | Journal of clinical pharmacology 20010201 |
| Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. | The American journal of gastroenterology 20010201 |
| Switching between intravenous and oral pantoprazole. | Journal of clinical gastroenterology 20010101 |
| Does pantoprazole alleviate mouth dryness in patients with Sjögren's syndrome? | Rheumatology (Oxford, England) 20010101 |
| Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. | Digestion 20010101 |
| Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. | The American journal of gastroenterology 20010101 |
| Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. | Digestion 20010101 |
| Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet. | Methods and findings in experimental and clinical pharmacology 20010101 |
| [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma]. | Recenti progressi in medicina 20010101 |
| Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. | Scandinavian journal of gastroenterology. Supplement 20010101 |
| The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. | British journal of clinical pharmacology 20001001 |
| An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes. | Chemico-biological interactions 19980703 |
| Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors. | Drug metabolism and disposition: the biological fate of chemicals 19970501 |
| Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. | Xenobiotica; the fate of foreign compounds in biological systems 19970101 |
| Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. | European journal of gastroenterology & hepatology 19961001 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.